According to Lin’s findings, increased expression of ARSD might contribute to amyloidosis in breast cancer cells, and therefore targeting ARSD could be a potential strategy for treating TNBC or Alzheimer’s disease (AD) (11). Here, ARSD is linked to breast cancer.